Amyris, Inc.

148 articles with Amyris, Inc.

• Amyris Closes Acquisitions Of OLIKA Inc. And MG Empower

  8/24/2021

  Amyris, Inc. (Nasdaq: AMRS), today announced that it closed the acquisitions of OLIKA, Inc. (OLIKA), an award-winning clean consumer brand, and MG Empower Ltd., a leading global influencer marketing agency on August 11.  

• Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine

  8/20/2021

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI).

• Amyris Launches Next Virtual Investor Mini-Series

  8/16/2021

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be hosting an encore to its first three-part virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology".

• Amyris, Inc. Reports Second Quarter 2021 Financial Results

  8/5/2021

  Amyris, Inc. today announced financial results for its second quarter ended June 30, 2021.

• Amyris to Present at the Oppenheimer 24th Annual Technology, Internet & Communications Conference on August 10, 2021

  8/3/2021

  Amyris, Inc. today announced that John Melo , President and Chief Executive Officer, will present at the Oppenheimer 24th Annual Technology Conference.

• Amyris To Host Second Quarter 2021 Financial Results Conference Call On August 5

  7/21/2021

   Amyris, Inc. today announced that it will issue its financial results for the second quarter ended June 30, 2021 on the morning of Thursday, August 5, 2021, prior to the opening of the financial markets.

• Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials

  7/1/2021

   Amyris, Inc. today announced that it has signed an exclusive license with Nant Africa , LLC relating to the development and use of the RNA Covid vaccine Amyris devloped in coordination with the Infectious Disease Research Institute.

• Amyris to Present at the Jefferies Virtual Consumer Conference on June 23, 2021

  6/16/2021

  Amyris, Inc. today announced that John Melo , President and Chief Executive Officer, will participate at the Jefferies Virtual Consumer Conference on Wednesday, June 23rd at 3:15 pm ET .

• Amyris To Acquire OLIKA Consumer Brand, Expanding Family Of Clean Consumer Brands And Accelerating Growth

  6/15/2021

  Amyris, Inc. (Nasdaq: AMRS), , today announced that it has executed a binding term sheet for the acquisition of award-winning, clean wellness company OLIKA Inc. (OLIKA)

• Amyris Clean Beauty Consumer Brands Expand By Over 10,000 North American Retail Doors

  5/18/2021

  Amyris, Inc., a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced that it has obtained commitments for over 10,000 new doors at retail stores such as Sephora North America, CVS, KeHe North America, Loblaws Super Saver, Rite Aid, Walgreens, Walmart Canada and Wegmans to sell Amyris clean beauty consumer products.

• Amyris to Present at the Virtual Morgan Stanley Global Consumer Ingredients Day on May 18, 2021

  5/11/2021

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that management will participate in a fireside chat at the virtual Morgan Stanley Global Consumer Ingredients Day on Tuesday, May 18 th at 10:45 am ET .

• Amyris, Inc. Reports First Quarter 2021 Financial Results

  5/6/2021

  Amyris, Inc., a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, announced financial results for its first quarter ended March 31, 2021.

• Amyris Brand Pipette™ Partners With Baby2baby To Help Babies And Families In Need

  5/5/2021

  Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced that Pipette™, its clean baby and mothers skincare brand, will partner with non-profit organization, Baby2Baby to donate 200,000 units of its award-winning hand sanitizer to families living in poverty nationwide.

• Amyris To Acquire EcoFabulous Clean Beauty Brand Focused On Fast-Growing Gen Z Consumer Segment

  4/15/2021

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of Gen Z-focused beauty brand, EcoFabulous Cosmetics (EcoFabulous).

• Amyris Announces Pricing of a $300.0 Million Public Offering (Secondary and Primary) of Common Stock

  4/9/2021

  Amyris, Inc. announced the pricing of an underwritten public offering of an aggregate of 19,047,619 shares of its common stock at a public offering price of $15.75 per share, which consists of a secondary offering of 11,390,797 shares to be sold, in the aggregate, by DSM International B.V. and affiliates of Vivo Capital LLC and 7,656,822 shares to be sold by Amyris.

• Amyris Announces Proposed Public Offering (Secondary And Primary) Of Common Stock

  4/7/2021

  Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the commencement of a proposed underwritten public offering of shares of its common stock.

• Amyris Brand Biossance® partners With Reese Witherspoon To Accelerate Clean Beauty Movement

  4/7/2021

  Amyris, Inc. announced a 5-year partnership with Reese Witherspoon as global brand ambassador for Biossance®, one of the fastest growing clean and sustainable skincare brands in the world.

• Amyris to Present at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on April 6, 2021

  4/5/2021

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will participate in a fireside chat at Cowen's 2 nd Annual Consumer Platforms for the Next Generation Summit

• Amyris To Host Third Webinar In Its Virtual Investor Mini-Series

  4/1/2021

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will host the third webinar in its virtual investor mini-series themed " Delivering on the Promise of Synthetic Biology"

• Amyris And DSM Close Significant Strategic Transaction To Accelerate The Growth Of Natural, Sustainable Ingredients

  3/31/2021

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has signed and closed an agreement with DSM Nutritional Products Ltd.